Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM‐HF

AIMS: Elevated serum uric acid concentration (SUA) has been associated with an increased risk of cardiovascular disease, but this may be due to unmeasured confounders. We examined the association between SUA and outcomes as well as the effect of sacubitril/valsartan on SUA in patients with heart fai...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Heart Fail
Autors principals: Mogensen, Ulrik M., Køber, Lars, Jhund, Pardeep S., Desai, Akshay S., Senni, Michele, Kristensen, Søren L., Dukát, Andrej, Chen, Chen‐Huan, Ramires, Felix, Lefkowitz, Martin P., Prescott, Margaret F., Shi, Victor C., Rouleau, Jean L., Solomon, Scott D., Swedberg, Karl, Packer, Milton, McMurray, John J.V.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2017
Matèries:
Focus on Clinical Trials
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607477/
https://ncbi.nlm.nih.gov/pubmed/29193563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.1056
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars